Your Article Summary
See Latest ArticlesRadiochemotherapy in locally advanced squamous cell carcinomas of the head and neck
Clinical Oncology, 06/24/09
Matzinger O et al. - In a review of radiochemotherapy in locally advanced squamous cell carcinomas of the head and neck (SCCHN), this overview reviews the most relevant published studies on the multidisciplinary management of SCCHN and discusses future strategies to reduce locoregional failures.
Methods- SCCHN is a common disease that develops in the upper aerodigestive epithelium.
- Most important risk factors are tobacco and alcohol consumption.
- There is increasing evidence that human papillomavirus plays an important role in the cause of SCCHN.
- The complex anatomy, the vital functions of the upper aerodigestive tract, and close proximity to vital structures, explain that the goal of treatment is not only to improve survival outcomes, but also to preserve organ function.
- Radiotherapy and surgery are standard modalities of treatment, reflecting the locoregional predominance of SCCHN.
- Chemotherapy plays an important role in treatment of pts with locoregionally advanced disease, in conjunction with radiotherapy and surgery.
- Standard therapy for resectable locoregionally advanced (stage III or IV) SCCHN cancers consists either of surgery and adjuvant chemoradiotherapy or definitive concomitant chemoradiotherapy, depending upon disease site, stage and resectability of the tumour, or institutional experience.
- Concomitant chemoradiotherapy has been shown in several randomised trials to improve disease-free (DFS) and overall survival (OS) in the postoperative setting for resected disease with poor prognostic factors.
- Multiple randomised studies and meta-analyses have shown that definitive chemoradiotherapy, as well anti-epidermal growth factor receptor treatment in 1 randomised study, improved DFS and OS when compared with radiotherapy alone.
Related Articles
A comparative review of the potential role of adenovirus and Herpes Simplex Virus in the treatment of advanced squamous cell carcinoma of the head and neck
Journal of Radiotherapy in Practice, 11/18/09
Relevance Score: 99%
Accelerated fractionation radiotherapy and late intensification with 2 intra-arterial cisplatin infusions for locally advanced head and neck squamous cell carcinoma
Head & Neck, 11/04/09
Relevance Score: 99%
Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer
Annals of Oncology, 10/20/09
Relevance Score: 99%
Definitive altered fractionation radiotherapy and concomitant weekly cisplatin for locally advanced head and neck cancer
American Journal of Clinical Oncology, 10/09/09
Relevance Score: 99%
Pretreatment prognostic factors influencing distant metastasis-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy
American Journal of Clinical Oncology, 10/09/09
Relevance Score: 99%
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Flat epithelial atypia is a common subtype of B3 breast lesions and associated with noninvasive cancer but not with invasive cancer in final excision histology
Human Pathology, 12/19/09
Diagnostic Accuracy of rhTSH Test with Neck Ultrasonography in Differentiated Thyroid Cancer Follow-up
Experimental and Clinical Endocrinology & Diabetes, 12/19/09
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Expression of p16 in benign and malignant cystic squamous lesions of the neck
Human Pathology, 12/19/09
Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas
Human Pathology, 12/19/09
Overexpression of Kif2a promotes the progression and metastasis of squamous cell carcinoma of the oral tongue
Oral Oncology , 12/19/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients
British Journal of Cancer, 12/17/09
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
British Journal of Cancer, 12/17/09
Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis
Annals of Hematology, 12/17/09